Research Article - (2022) Volume 10, Issue 9
The Gas Chromatography Mass Spectroscopy Analysis of One Unani Drug, "Zimad Aouja"
Hassan Mohammad M1, Janaki CS2, Rao MRK3*, Prabhu K4, Deepa K5, Franklin6 and Vijayalakshmi N7
*Correspondence: Rao MRK, Department of Anatomy, Amritha University, Thiruporur, Tamil Nadu, India, Email:
Abstract
The Unani drug, “Zimad Aouja”, is prescribed for joint sprains. The medicine was bought from Unani medicine supplier and was processed suitably for gas chromatography mass spectroscopic analysis. The profile showed metabolites, namely, 1-Hexadecyn-3-ol, 3,7,11,15-tetramethyl-, p-Menthane, 2,3-dibromo-8-phenyl-, Trichloroacetic acid, dodec-9-ynyl ester, Artumerone, Curlone, Benzenebutanal, gamma,4-dimethyl-, Methyl 4,7,10,13-hexadecatetraenoate, Tetradecanedioic acid, 6- Octadecenoic acid etc. which show promising medicinal roles. These medicinal roles could lead to the function of the medicine to cure the ailments for which this medicine is prescribed.
Keywords
GCMS, Zimad Aouja, Unani, Ar-tumerone, Curlone, Benzenebutanal, Tetradecanedioic acid, 6-Octadecenoic acidIntroduction
Zimad aouja is powder form of Unani medicine which contains mostly turmeric (Curcuma longa). When mixed with water it becomes and paste which is used to treat joint sprains. It can also be mixed with vinegar or hot water and spread on a cloth which is then applied to affected areas. It is imperative to establish the authenticity of alternative medicines such as Ayurveda, Sidhha and Unani systems as they are time tested and in use for centuries. The present workers have worked to scientifically evaluate the veracity of these medicine systems by latest techniques so that deeper knowledge of the mechanism of action of these medicines could be gained [1-19]. Not much work in this direction is reported as far as Zimad Aouja is concerned.
Materials and Methods
The drug, Zimad Aouja was bought from Unani medicine supplier and was suitably processed by standard procedures for the analysis.
Results
The Unani medicine Zimad Aouja gas chromatography mass spectroscopic profile and possible medicinal role of molecules is tabulated in Table 1.
Ret. Time | Molecule | Mol. Formula | Mol. Mass | % Peak Area | Possible Medicinal Role |
---|---|---|---|---|---|
4.55 | Cyclopentane, 1-pentyl-2-propyl- | C13H26 | 182.2 | 1.46 | Not known |
4.61 | Ribitol | C5H12O5 | 152.1 | 1.04 | Not known |
4.82 | Benzene, 1,3-bis(1,1-dimethylethyl)- | C14H22 | 190.2 | 4.29 | Not known |
5.25 | Dodecane, 1-fluoro- | C12H25F | 188.2 | 4.59 | Not known |
6.51 | 2-Methoxy-4-vinylphenol | C9H10O2 | 150.1 | 1.15 | Not known |
7.53 | Phenol, 2,4-bis(1,1-dimethylethyl)- | C14H22O | 206.2 | 1.56 | Not known |
7.99 | 1-Hexadecyn-3-ol, 3,7,11,15-tetramethyl- | C20H38O | 294.3 | 0.63 | Oligosaccharide provider |
8.26 | p-Menthane, 2,3-dibromo-8-phenyl- | C16H22Br2 | 372 | 0.9 | Adrenalin pressor, Anti-cAMP-Phosphodiesterase, anticancer, antidote, antimitral valve prolapse |
8.88 | Trichloroacetic acid, dodec-9-ynyl ester | C14H21C13O2 | 326.1 | 0.68 | Arachidonic acid-inhibitor, increases aromatic amino Acid decarboxylase activity, inhibits production of uric Acid, |
9.23 | Ar-tumerone | C15H20O | 216.2 | 22.67 | Arachidonic acid Inhibitor, arginine rich, aromatase inhibitor, Arterioconstrictor, aryl hydrocarbon hydroxylase inhibitor, arylamine-N-acetyltransferase inhibitor, increases aromatic amino acid decarboxylase activity, adrenaline pressor, alogenic, anti-cAMP phosphodiesterase, anticancer |
9.35 | Curlone | C15H22O | 218.2 | 5.2 | Oligosaccharide provider |
9.5 | Benzenebutanal, gamma,4-dimethyl- | C12H16O | 176.1 | 0.59 | PPAR-Gamma antagonistic |
10.41 | Methyl 4,7,10,13-hexadecatetraenoate | C17H26O2 | 262.2 | 0.77 | Catechol-o-methyl-transferase-inhibitor, methyl-donor, methyl-guanidine-inhibitor |
11.3 | 3-Buten-2-one, 4-(4-hydroxy-3-methoxyphenyl)- | C11H12O3 | 192.1 | 1.28 | Not known |
11.61 | Methyl 16-hydroxy-hexadecanoate | C17H34O3 | 286.3 | 0.97 | 17 beta hydroxysteroid dehydrogenase inhibitor, Aryl hydrocarbon hydroxylase inhibitor, testosterone hydroxylase inducer |
13.78 | Palmitoyl chloride | C16H31ClO | 274.2 | 0.95 | Not known |
14.3 | Tetradecanedioic acid | C14H26O4 | 258.2 | 3.87 | Increases aromatic amino acid decarboxylase activity, inhibit production of uric acid, |
14.9 | Decanamide, N-(2-hydroxyethyl)- | C12H25NO2 | 215.2 | 0.9 | Not known |
16.22 | 6-Octadecenoic acid | C18H34O2 | 282.3 | 5.47 | Increases aromatic amino acid decarboxylase activity, inhibit production of uric acid |
16.82 | 9-Octadecenoic acid, (E)- | C18H34O2 | 282.3 | 16.84 | Not known |
17.07 | Butyl 9,12,15-octadecatrienoate | C22H38O2 | 334.3 | 15.63 | Not Known |
Table 1: Indicates the retentions values, types of possible compound, their molecular formulae, molecular mass, peak area and their medicinal roles of each compound as shown in the GC MS profile of Zimad Aouja.
Figure 1 shows the gas chromatography mass spectroscopic of the Unani medicine Zimad Aouja. The identification of metabolites was accomplished by comparison of retention time and fragmentation pattern with mass spectra in the NIST spectral library stored in the computer software (version 1.10 beta, Shimadzu) of the GC-MS along with the possible pharmaceutical roles of each bio molecule as per Dr. Duke’s phytochemical and ethnobotanical data base (National Agriculture Library, USA) and others as shown in Table 1 [20].
Figure 1: Indicates the Gas chromatography mass spectroscopic profile of Zimad Aouja.
Discussion
The gas chromatography mass spectroscopic profile of Zimad Aouja showed compounds, namely, 1-Hexadecyn-3-ol, 3,7,11,15-tetramethyl-, p-Menthane, 2,3-dibromo-8-phenyl-, Trichloroacetic acid, dodec-9-ynyl ester, Ar-tumerone, Curlone, Benzenebutanal, gamma,4-dimethyl-, Methyl 4,7,10,13-hexadecatetraenoate, Tetradecanedioic acid, 6-Octadecenoic acid etc. which have important medicinal roles as shown in Table 1. These medicinal roles must be attributed to the medicinal role of Zimad aouja which is prescribed pain relief due to sprains etc.
Conclusion
It could be summarized from the results and discussion that Zimad Aouja does contain important biomolecules which provides a clue to its prescription for the ailments it is given. Some of the molecules shown in the GCMS profile for which the medicinal roles are not known could be further probed.
Acknowledgement
The authors thankfully acknowledge the support of all the people and organizations.
References
- Rao MRK, Philip S, Kumar MH, et al. GC-MS analysis, antimicrobial, antioxidant activity of an Ayurvedic medicine, Salmali Niryasa. J Chem Pharm Res 2015; 7:131-139.
- Sivakumaran G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one ayurvedic oil, Anu thailam. DIT 2019; 11:2675-2678.
- Sivakumaran G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one ayurvedic oil, Ksheerabala Thailam. DIT 2019; 11: 2661-2665.
- Sivakumaran G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one Ayurvedic oil, Triphaladi Thailam. DIT 2019; 11:2679-2683.
- Narayanan G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one Ayurvedic medicine, Drakshadi Kashayam. DIT 2019; 11: 2652-2656.
- Narayanan G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one ayurvedic medicine, Kutajarishtam. DIT 2019; 11:2666-2669.
- Narayanan G, Prabhu K, Rao MRK, et al. Gas chromatography–mass spectrometry analysis of one Ayurvedic antiobesity medicine, Lohasava. DIT 2019; 11:2670-2674.
- Kumar MH, Prabhu K, Rao MRK, et al. Gas chromatography/mass spectrometry analysis of one Ayurvedic skin oil, Eladi Kera Thailam. DIT 2019; 11:2657-2660.
- Mohammad H, Prabhu K, Rao MRK, et al. The GC MS study of one Ayurvedic Pain relieving OIL "Mahamasha thailam". Drug Discov Today 2019; 12:1524-1527.
- Mohammad H, Prabhu K, Rao MRK, et al. The GC MS study of one Ayurvedic Pain relieving oil "Karpooradi thailam", Drug Invention Today, 2019; 12:1542-1546.
- Prabhu J, Prabhu K, Chaudhury A, et al. Neuro protective role of Saraswatharishtam on Scopolamine induced memory impairment in animal model. Pharmacogn J 2020; 12:465-472.
- Prabhu K, Rao MRK, Bharath AK, et al. The GC MS study of one Ayurvedic Rasayana formulation Narasimha Rasayanam. DIT 2020; 13:658-662.
- Prabhu K, Rao MRK, Vishal SK, et al. GC MS study of one Ayurvedic Rasayana drug, Dhanwantari Rasayanam. DIT 2020; 14:783-786.
- Sharmila D, Poovarasan A, Pradeep E, et al. GC MS analysis of one Ayurvedic formulation, Sitopaladi. RJPT 2021; 14:911-915.
- Narayanan G, Prabhu K, Chaudhuri A, et al. Cardio protective role of Partharishtam on isoproterenol induced myocardial infarction in animal model. Pharmacogn J 2021; 13:591-595.
- Kalivannan J, Janaki CS, Rao MRK, et al. The GC MS astudy of one ayurvedic formulation, Chandanasavam. Ind J of Nat Sci 2021; 12:33671-33676.
- Akshaya SR, Kalaivani S, Prabhu K, et al. The GC MS study of one Ayurvedic churnam, Avalgujabijadi churnam. Ind J of Nat Sci 2021; 12:34395-34402.
- Subbiah AJ, Kavimani M, Rao MRK, et al. The GC MS study of one Ayurvedic. Formulation, Pushyanuga churnam. Ind J Nat Sci 2021; 12:35757-357-366.
- Yuvaraj R, Vijayakumar S, Rao MRK et al. The GC MS study of one Ayurvedic medicine Pippalyasavam'. Ind J of Nat Sci 2021; 12:35612-35618.
- Duke, James A. Duke's Phytochemcial and Ehnobotanical Databases. U.S. Department of Agriculture, Agricultural Research Service. Ag Data Commons, U.S, 2021.
Author Info
Hassan Mohammad M1, Janaki CS2, Rao MRK3*, Prabhu K4, Deepa K5, Franklin6 and Vijayalakshmi N7
1Department of Anatomy, Northern Borders University, Arar, Saudi Arabia2Department of Anatomy, Bhaarath Medical College, Chennai, Tamilnadu, India
3Department of Anatomy, Amritha University, Thiruporur, Tamil Nadu, India
4Department of Anatomy, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
5Department of Anatomy, Quest International University, IPOH Perak, Malaysia
6Dept of Microbiology, CEO Anna Medical College, Mauritius, Montagne Blanche, Island, Mauritius
7Department of Chemical and Biotechnology, SASTRA (Deemed to be University), Thanjavur, Tamil Nadu, India
Received: 04-Jul-2022, Manuscript No. JRMDS-22-57371; , Pre QC No. JRMDS-22-57371; Editor assigned: 07-Jul-2022, Pre QC No. JRMDS-22-57371; Reviewed: 21-Jul-2022, QC No. JRMDS-22-57371; Revised: 05-Sep-2022, Manuscript No. JRMDS-22-57371; Published: 12-Sep-2022